Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
4,301
Views
22
CrossRef citations to date
0
Altmetric
Back Matter

HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer

Yingxue Rena Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Yesesri Cherukuria Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Daniel P. Wicklanda Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Vivekananda Sarangib Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Shulan Tianb Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USAView further author information
,
Jodi M. Carterc Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAView further author information
,
Aaron S. Mansfieldd Division of Medical Oncology, Mayo Clinic, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-9483-6903View further author information
ORCID Icon,
Matthew S. Blockd Division of Medical Oncology, Mayo Clinic, Rochester, MN, USAView further author information
,
Mark E. Shermana Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Keith L. Knutsone Department of Immunology, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Yi Linf Division of Hematology, Mayo Clinic, Rochester, MN, USAView further author information
&
Yan W. Asmanna Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USACorrespondence[email protected]
View further author information
 show all
Article: 1744947 | Received 06 Nov 2019, Accepted 17 Feb 2020, Published online: 01 Apr 2020

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ravi Velaga, Kevin M Koo & Paul N Mainwaring. (2022) Harnessing Gene Fusion-Derived Neoantigens for ‘Cold’ Breast and Prostate Tumor Immunotherapy. Immunotherapy 14:14, pages 1165-1179.
Read now

Articles from other publishers (21)

Yanhao Liu, Xu Jiang, Yujuan Wu & Haiming Yu. (2024) Global research landscape and trends of cancer radiotherapy plus immunotherapy: A bibliometric analysis. Heliyon 10:5, pages e27103.
Crossref
Milena Ivanova, Anastasia Ormandjieva, Rumyana Dodova, Radka Kaneva & Velizar Shivarov. (2023) Possible impact of HLA class I and class II on malignancies driven by a single germ‐line BRCA1 mutation . International Journal of Immunogenetics 50:5, pages 243-248.
Crossref
Weiqiang Qiao, Zhiqiang Jia, Wanying Guo, Qipeng Liu, Xiao Guo & Miao Deng. (2023) Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis. Molecular Diagnosis & Therapy 27:5, pages 573-582.
Crossref
Lingeng Lu, Wenxue Ma, Caroline H. Johnson, Sajid A. Khan, Melinda L. Irwin & Lajos Pusztai. (2023) In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer. Vaccine 41:12, pages 2073-2083.
Crossref
Lisa M James & Apostolos P Georgopoulos. (2023) Immunogenetic Profiles and Associations of Breast, Cervical, Ovarian, and Uterine Cancers. Cancer Informatics 22, pages 117693512211485.
Crossref
Joshua Ogony, Tanya L. Hoskin, Melody Stallings-Mann, Stacey Winham, Rushin Brahmbhatt, Muhammad Asad Arshad, Nagarajan Kannan, Alvaro Peña, Teresa Allers, Alyssa Brown, Mark E. Sherman, Daniel W. Visscher, Keith L. Knutson, Derek C. Radisky & Amy C. Degnim. (2022) Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. Breast Cancer Research and Treatment 197:2, pages 277-285.
Crossref
Yueqiong Lao, Yuqian Wang, Jie Yang, Tianyuan Liu, Yuling Ma, Yingying Luo, Yanxia Sun, Kai Li, Xuan Zhao, Xiangjie Niu, Yiyi Xi & Ce Zhong. (2022) Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in Oncology 12.
Crossref
Qiao Zhang, Qingzhu Jia, Jing ZhangBo Zhu. (2022) Neoantigens in precision cancer immunotherapy: from identification to clinical applications. Chinese Medical Journal 135:11, pages 1285-1298.
Crossref
Mary L. Disis & Denise L. Cecil. (2021) Breast cancer vaccines for treatment and prevention. Breast Cancer Research and Treatment 191:3, pages 481-489.
Crossref
Xianzhu Fang, Zhiliang Guo, Jinqing Liang, Jiao Wen, Yuanyuan Liu, Xiumei Guan & Hong Li. (2022) Neoantigens and their potential applications in tumor immunotherapy (Review). Oncology Letters 23:3.
Crossref
Connor J. Liu, Andrew T. Coxon & Gavin P. Dunn. 2022. Immunotherapeutic Strategies for the Treatment of Glioma. Immunotherapeutic Strategies for the Treatment of Glioma 19 38 .
Xue-lin Zou, Xiao-bo Li, Hua Ke, Guang-yan Zhang, Qing Tang, Jiao Yuan, Chen-jiao Zhou, Ji-liang Zhang, Rui Zhang & Wei-yong Chen. (2021) Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer. Frontiers in Immunology 12.
Crossref
Chuanpeng Dong, Annamaria Cesarano, Giuseppe Bombaci, Jill L. Reiter, Christina Y. Yu, Yue Wang, Zhaoyang Jiang, Mohammad Abu Zaid, Kun Huang, Xiongbin Lu, Brian A. Walker, Fabiana Perna & Yunlong Liu. (2021) Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma. Oncogene 40:42, pages 6130-6138.
Crossref
Wenjing Li, Amei Amei, Francis Bui, Saba Norouzifar, Lingeng Lu & Zuoheng Wang. (2021) Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers 13:12, pages 2879.
Crossref
Leticia De Mattos-Arruda, Javier Cortes, Juan Blanco-Heredia, Daniel G. Tiezzi, Guillermo Villacampa, Samuel Gonçalves-Ribeiro, Laia Paré, Carla Anjos Souza, Vanesa Ortega, Stephen-John Sammut, Pol Cusco, Roberta Fasani, Suet-Feung Chin, Jose Perez-Garcia, Rodrigo Dienstmann, Paolo Nuciforo, Patricia Villagrasa, Isabel T. Rubio, Aleix Prat & Carlos Caldas. (2021) The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. npj Breast Cancer 7:1.
Crossref
Yanyi Huang, Jinzhong Duanmu, Yushu Liu, Mengyun Yan, Taiyuan Li & Qunguang Jiang. (2021) Analysis of multi-omics differences in left-side and right-side colon cancer. PeerJ 9, pages e11433.
Crossref
Peipei Wang, Yueyun Chen & Chun Wang. (2021) Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy. Frontiers in Oncology 11.
Crossref
Aitziber Buqué, Maria Perez-Lanzón, Giulia Petroni, Juliette Humeau, Norma Bloy, Takahiro Yamazaki, Ai Sato, Guido Kroemer & Lorenzo Galluzzi. 2021. Carcinogen-driven mouse models of oncogenesis. Carcinogen-driven mouse models of oncogenesis 1 19 .
Jitka Fucikova, Oliver Kepp, Lenka Kasikova, Giulia Petroni, Takahiro Yamazaki, Peng Liu, Liwei Zhao, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease 11:11.
Crossref
Joshua W. Ogony, Derek C. Radisky, Kathryn J. Ruddy, Steven Goodison, Daniel P. Wickland, Kathleen M. Egan, Keith L. Knutson, Yan W. Asmann & Mark E. Sherman. (2020) Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women. Cancer Prevention Research 13:11, pages 901-910.
Crossref
Benjamin Gordon & Vijayakrishna K. Gadi. (2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines 8:3, pages 529.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.